Ultrasound exams of patients with a history of idiopathic carpal tunnel are better diagnostic tools than the standard physical maneuvers known as Tinel’s sign and Phalen’s maneuver.
Ultrasound exams of patients with a history of idiopathic carpal tunnel are better diagnostic tools than the standard physical maneuvers known as Tinel's sign and Phalen's maneuver.
Dr. Antonio Naranjo and colleagues in the rheumatology department at the University of Las Palmas de Gran Canaria, Spain, published their study in the November/December 2007 issue of the Journal of Clinical and Experimental Rheumatology. They studied 68 patients with 105 wrists showing symptoms of carpal tunnel syndrome.
To be included in the study, patients had to have experienced a loss of pain sensation along the median nerve daily for at least three months, and the results of a nerve conduction study on the wrist had to be positive. Cases were not excluded if they had negative results with Phalen's maneuver or Tinel's sign.
A rheumatologist who was blinded to the earlier diagnoses conducted ultrasound exams on all cases, checking the median nerve from the inlet to the outlet of the carpal tunnel. He measured the mean cross-sectional area at each level, flattening ratio, and bowing of the flexor retinaculum.
The results showed that ultrasound measurements were more sensitive, specific, and accurate than Tinel's and Phalen's signs. The researchers achieved a 100% positive predictive value using a swelling nerve cutoff of 13 mm2at the tunnel inlet. This involved 33 hands, or 31% of the group. The most effective swelling nerve cutoff was 9.7 mm2 at the tunnel inlet, at 86% sensitivity, 48% specificity, and 77% accuracy.
Using measurements of the maximal cross-sectional area resulted in an accuracy of 72%, and measurements of the flexor retinaculum had an accuracy of 73%. Researchers found Tinel's sign, the standard diagnostic physical maneuver, was 73% sensitive and 40% specific, and Phalen's maneuver was 67% sensitive and 30% specific.
Combining the results of the physical tests and sonography was not more accurate than using the cross-sectional area alone.
The researchers concluded that ultrasound has a higher diagnostic value than physical maneuvers for patients with idiopathic carpal tunnel syndrome.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.